Correlation between pelvic active bone marrow and hematological toxicity in radiotherapy of cervical cancer
LIU Jingwen1, REN Hongrong2, ZHOU Chong3, ZHOU Yun3, WANG Tao4, YIN Haitao3
1. Research Institute of Xuzhou Medical University-Oncology major; Xuzhou 221000 China; 2. Xuzhou Central Hospital-Physical Planning Department; 3. Xuzhou Central Hospital-Radiotherapy Department; 4. Xuzhou Central Hospital- Department of Photography
[1] 农秋锋. 宫颈癌疫苗及其应用研究进展[J]. 内科,2020,15(1):57-59 [2] 柴淑霞. 宫颈癌流行病学及高危因素探讨[J]. 世界最新医学信息文摘(电子版),2017,17(63):189-190 [3] Sun W Z, Wang T, Shi F, et al. Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy[J]. BMC Cancer, 2015, 15: 353 [4] Green J A, Kirwan J M, Tierney J F, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis[J]. Lancet, 2001, 358(9284): 781-786 [5] Torres M A, Jhingran A, Thames H D Jr, et al. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment[J]. Int J Radiat Oncol, 2008, 70(1): 118-125 [6] Vande Berg B C, Malghem J, Lecouvet F E, et al. Magnetic resonance imaging of normal bone marrow[J]. Eur Radiol, 1998, 8(8): 1327-1334 [7] Igarashi H, Kouro T, Yokota T, et al. Age and stage dependency of estrogen receptor expression by lymphocyte precursors[J]. Proc Natl Acad Sci U S A, 2001, 98(26): 15131-15136 [8] Shim G J, Wang L, Andersson S, et al. Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis[J]. Proc Natl Acad Sci U S A, 2003, 100(11): 6694-6699 [9] 张庆红, 曹军, 胡玉珍, 等. 雌激素和雌激素受体参与造血和免疫功能调节的研究进展[J]. 生理科学进展,2004,35(3):277-280 [10] Gay H A, Barthold H J, O'Meara E, et al. Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas[J]. Int J Radiat Oncol Biol Phys, 2012, 83(3): e353-e362 [11] 李钰, 高岩, 刘世龙, 等. 宫颈癌患者的膀胱充盈度一致性对放疗摆位误差的影响[J]. 中国辐射卫生,2020,29(3):305-308 [12] 苗慧, 施林心, 白海生, 等. 宫颈癌不同体位调强放疗对周围正常组织的辐射剂量学研究[J]. 中国辐射卫生,2018,27(4):381-384 [13] 杨琦, 汪善兵, 刘佳培, 等. 99Tcm硫胶体-SPECT骨髓显像对局部晚期宫颈癌同步放化疗中血液性毒性的预测[J]. 国际医学放射学杂志,2019,42(4):405-408 [14] 袁佳, 常建英, 李凤虎, 等. 宫颈癌术后调强放疗髂骨骨髓受量与血液学毒性相关性研究[J]. 中华肿瘤防治杂志,2015,22(21):1708-1712 [15] 张泽高, 热伊拉·麦买提伊敏, 哈斯也提·外里, 等. 基于≥2级骨髓抑制盆腔肿瘤放疗骨受剂量体积限制分析[J]. 中华放射肿瘤学杂志,2019,28(12):905-908 [16] Noticewala S S, Li N, Williamson C W, et al. Longitudinal changes in active bone marrow for cervical cancer patients treated with concurrent chemoradiation therapy[J]. Int J Radiat Oncol Biol Phys, 2017, 97(4): 797-805 [17] Li Z R, Hardij J, Bagchi D P, et al. Development, regulation, metabolism and function of bone marrow adipose tissues[J]. Bone, 2018, 110: 134-140
